Markers for the Severity of Multisystem Inflammatory Syndrome in Children: A Multivariate Analysis

Georgi Vasilev1,2, Nadzhie Gorelyova3, Russka Shumnalieva2,4

  • 1Laboratory of Clinical Immunology, National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.

Insights

Multisystem inflammatory syndrome in children (MIS-C) can be graded by clinical severity using laboratory data. Age, ferritin, and LDH levels help predict MIS-C severity and organ involvement.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Clinical laboratory science

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) presents a significant clinical challenge.
  • Accurate grading of MIS-C severity and organ involvement is crucial for effective management.
  • Predictive biomarkers are needed for risk stratification and prognosis.

Purpose of the Study:

  • To grade children with MIS-C by clinical severity and system involvement.
  • To identify key predictors and develop scoring systems for disease prognosis.
  • To stratify patients based on multivariate clinical laboratory data.

Main Methods:

  • Clustering analysis (K-means) on kernel principal component analysis (K-PCA) projections of 34 laboratory parameters.
  • Receiver operating characteristic (ROC) curve analysis and logistic regression.
  • Analysis of clinical data including inotropic support and respiratory distress.

Main Results:

  • Three distinct clusters of MIS-C patients were identified based on laboratory profiles.
  • Cluster 3 showed significantly higher levels of ferritin, LDH, liver enzymes, and kidney function markers.
  • Age ≥9 years, ferritin >470 ng/mL, and LDH >363 U/L were identified as predictors of severe kidney/liver involvement and higher severity clusters.

Conclusions:

  • Clustering effectively grades MIS-C severity and stages of liver and kidney involvement.
  • LDH, ferritin, and age are valuable indicators for assessing MIS-C severity.
  • These markers aid in clinical assessment and risk stratification for improved patient outcomes.
Abstract

Related Concept Videos